Atria Investments’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$940K Sell
9,066
-2,755
-23% -$312K 0.01% 1087
2025
Q4
$1.19M Sell
11,821
-2,190
-16% -$238K 0.01% 980
2025
Q3
$1.73M Sell
14,011
-4,649
-25% -$577K 0.02% 778
2025
Q2
$2.24M Sell
18,660
-2,459
-12% -$328K 0.03% 677
2025
Q1
$3.11M Buy
21,119
+3,606
+21% +$551K 0.04% 532
2024
Q4
$2.84M Sell
17,513
-1,065
-6% -$174K 0.04% 546
2024
Q3
$3.03M Sell
18,578
-401
-2% -$59.4K 0.04% 524
2024
Q2
$2.59M Buy
18,979
+1,056
+6% +$147K 0.03% 553
2024
Q1
$2.74M Buy
17,923
+653
+4% +$97.5K 0.04% 536
2023
Q4
$2.46M Sell
17,270
-100
-0.6% -$13.3K 0.04% 523
2023
Q3
$2.28M Buy
17,370
+362
+2% +$55K 0.04% 525
2023
Q2
$2.7M Sell
17,008
-5,273
-24% -$851K 0.05% 456
2023
Q1
$3.53M Sell
22,281
-5,304
-19% -$795K 0.07% 346
2022
Q4
$3.87M Buy
27,585
+1,302
+5% +$185K 0.08% 313
2022
Q3
$3.38M Buy
26,283
+4,409
+20% +$636K 0.07% 318
2022
Q2
$3.08M Sell
21,874
-379
-2% -$54.1K 0.06% 369
2022
Q1
$3.09M Buy
22,253
+5,015
+29% +$769K 0.05% 415
2021
Q4
$3.01M Sell
17,238
-9
-0.1% -$1.5K 0.05% 408
2021
Q3
$2.86M Buy
17,247
+3,404
+25% +$586K 0.05% 407
2021
Q2
$2.49M Buy
13,843
+2,353
+20% +$429K 0.05% 425
2021
Q1
$2.22M Buy
11,490
+2,241
+24% +$431K 0.05% 419
2020
Q4
$1.87M Buy
9,249
+350
+4% +$72.4K 0.05% 436
2020
Q3
$1.87M Sell
8,899
-16,160
-64% -$3.6M 0.06% 362
2020
Q2
$5.5M Buy
+25,059
New +$5.01M 0.19% 137
2020
Q1
Sell
-2,565
Closed -$394K 657
2019
Q4
$394K Sell
2,565
-24,394
-90% -$3.65M 0.01% 877
2019
Q3
$4.09M Buy
26,959
+1,084
+4% +$171K 0.15% 137
2019
Q2
$4.12M Buy
25,875
+3,925
+18% +$600K 0.15% 128
2019
Q1
$3.52M Buy
21,950
+3,857
+21% +$598K 0.15% 129
2018
Q4
$2.79M Buy
18,093
+171
+1% +$26.6K 0.12% 130
2018
Q3
$2.7M Buy
17,922
+670
+4% +$95.2K 0.11% 166
2018
Q2
$2.33M Buy
+17,252
New +$2.13M 0.1% 201
2015
Q1
Sell
-2,794
Closed -$291K 406
2014
Q4
$291K Sell
2,794
-281
-9% -$28.1K 0.03% 333
2014
Q3
$295K Buy
+3,075
New +$278K 0.03% 364

Other funds holding CLX

Atria Investments's CLX Position: Q1 2026 in Review

Atria Investments reduced its Clorox (CLX) stake by 23% in Q1 2026, selling an estimated $312K and leaving 9,066 shares worth $940K. The position accounts for 0.01% of the portfolio, ranked #1087.

Atria Investments first reported a position in CLX in Q3 2014 and has held it in 33 quarters since. The position peaked at $5.5M in Q2 2020. 1,080 funds tracked by Wall St. Rank hold CLX as of Q1 2026.

  • Atria Investments held 9,066 shares of Clorox worth $940K as of Q1 2026.
  • Atria Investments sold 2,755 Clorox shares in Q1 2026, an estimated $312K.
  • Clorox made up 0.01% of Atria Investments's portfolio in Q1 2026, its #1087 holding.
  • Atria Investments first reported a position in Clorox in Q3 2014 and has held it in 33 quarters since.
  • Atria Investments's Clorox position peaked at $5.5M in Q2 2020.
  • 1,080 funds tracked by Wall St. Rank held Clorox as of Q1 2026.

Based on Atria Investments's 13F filing for Q1 2026, filed 5 May 2026.